Novogene Technology Receives $75,000,000 Series B Funding Round
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=94c4096a-1d7b-4a5f-aec2-e7468ed5a827 -
Date
12/1/2016 -
Company Name
Novogene Technology -
Mailing Address
823 Anchorage Place Chula Vista, CA 91914 USA -
Company Description
Novogene is a leading provider of genomic services and solutions with cutting edge NGS and bioinformatics expertise and one of the largest sequencing capacities in the world. -
Website
http://www.novogene.com -
Transaction Type
Venture Equity -
Transaction Amount
$75,000,000 -
Transaction Round
Series B -
Proceeds Purposes
The Series B financing will support strategic growth in Novogene’s global NGS service market and in clinical sequencing R&D and services. Additionally, funds from the financing will be used to enhance operating efficiency to further strengthen the company’s leadership position in the NGS industry. -
M&A Terms
-
Venture Investor
CMB Capital -
Venture Investor
Innovation and Investment Company -
Venture Investor
Sigma Group
